Stifel raised the firm’s price target on Adentra (HDIUF) to C$51 from C$50 and keeps a Buy rating on the shares.Discover the Best Stocks and ...
In a report released today, Alex Thompson CFA from Stifel Nicolaus maintained a Buy rating on Immunovant (IMVT – Research Report), with a price ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results